QQ客服 官方微博 反馈留言

浏览/检索结果: 共6条，第1-6条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Twin Boundary Superstructures Assembled by Periodic Segregation of Solute Atoms 期刊论文 NANO LETTERS, 2021, 卷号: 21, 期号: 22, 页码: 9642-9650 作者:  Xie, Hongbo;  Pan, Hucheng;  Bai, Junyuan;  Xie, Dongsheng;  Yang, Peijun 收藏  |  浏览/下载：16/0  |  提交时间：2022/07/01 Interface  Twin boundary  Segregation  Superstructure  Dislocation  Magnesium alloy   Nonsymmetrical Segregation of Solutes in Periodic Misfit Dislocations Separated Tilt Grain Boundaries 期刊论文 NANO LETTERS, 2021, 卷号: 21, 期号: 7, 页码: 2870-2875 作者:  Xie, Hongbo;  Huang, Qiuyan;  Bai, Junyuan;  Li, Shanshan;  Liu, Yang 收藏  |  浏览/下载：21/0  |  提交时间：2021/10/15 Interface segregation  Misfit dislocation  Tilt grain boundary  Superstructure  Magnesium alloy   Efficacy and Tolerability of First-Line Cetuximab Plus Leucovorin, Fluorouracil, and Oxaliplatin (FOLFOX-4) Versus FOLFOX-4 in Patients With RAS Wild-Type Metastatic Colorectal Cancer: The Open-Label, Randomized, Phase III TAILOR Trial 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2018, 卷号: 36, 期号: 30 作者:  Qin, Shukui;  Li, Jin;  Wang, Liwei;  Xu, Jianming;  Cheng, Ying 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/04 Efficacy and Tolerability of First-Line Cetuximab Plus Leucovorin, Fluorouracil, and Oxaliplatin (FOLFOX-4) Versus FOLFOX-4 in Patients With RAS Wild-Type Metastatic Colorectal Cancer: The Open-Label, Randomized, Phase III TAILOR Trial 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2018, 卷号: 36, 期号: 30 作者:  Xiong, Jianping;  Qin, Shukui;  Li, Jin;  Wang, Liwei;  Xu, Jianming 收藏  |  浏览/下载：6/0  |  提交时间：2019/12/05 Efficacy and Tolerability of First-Line Cetuximab Plus Leucovorin, Fluorouracil, and Oxaliplatin (FOLFOX-4) Versus FOLFOX-4 in Patients With RAS Wild-Type Metastatic Colorectal Cancer: The Open-Label, Randomized, Phase III TAILOR Trial 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2018, 卷号: 36, 期号: 30 作者:  Qin, Shukui;  Li, Jin;  Wang, Liwei;  Xu, Jianming;  Cheng, Ying 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05 Efficacy and Tolerability of First-Line Cetuximab Plus Leucovorin, Fluorouracil, and Oxaliplatin (FOLFOX-4) Versus FOLFOX-4 in Patients With RAS Wild-Type Metastatic Colorectal Cancer: The Open-Label, Randomized, Phase III TAILOR Trial. 期刊论文 Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018, 卷号: 36, 期号: 30, 页码: JCO2018783183 作者:  Qin, Shukui;  Li, Jin*;  Wang, Liwei;  Xu, Jianming;  Cheng, Ying 收藏  |  浏览/下载：9/0  |  提交时间：2019/12/03